← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2019Last known activity
Nov 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 5 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT06891950CollaboratorPhase 3Nov 30, 2025
- NCT06842173CollaboratorPhase 1/Phase 2Sep 1, 2025
- NCT05779020CollaboratorPhase 3Apr 25, 2023
- NCT03998592CollaboratorPhase 1Oct 31, 2019
- NCT03927131CollaboratorPhase 3Jul 1, 2019
Details
- Last known activity
- Nov 30, 2025